Sonic Healthcare Ltd
F:SAB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Sonic Healthcare Ltd
F:SAB
|
AU |
Sonic Healthcare Ltd
Sonic Healthcare is a medical diagnostics company. It runs networks of pathology laboratories, medical centers, and other testing services that help doctors diagnose illness and monitor treatment. It also provides some radiology and related healthcare services in a few markets. Its main customers are doctors, hospitals, clinics, insurers, and public health systems, plus patients who need tests. Sonic makes money by charging for each test or service it performs, with much of that work paid for through health insurance or government reimbursement. In simple terms, it sits in the middle of the healthcare system and turns lab samples and scans into the information doctors need. What makes Sonic’s business model different is that it is built around a large, decentralized network of local laboratories rather than one single product. Demand is tied to everyday medical care, so the business depends less on a one-time sale and more on repeat testing from patients and physicians over time.
Sonic Healthcare is a medical diagnostics company. It runs networks of pathology laboratories, medical centers, and other testing services that help doctors diagnose illness and monitor treatment. It also provides some radiology and related healthcare services in a few markets.
Its main customers are doctors, hospitals, clinics, insurers, and public health systems, plus patients who need tests. Sonic makes money by charging for each test or service it performs, with much of that work paid for through health insurance or government reimbursement. In simple terms, it sits in the middle of the healthcare system and turns lab samples and scans into the information doctors need.
What makes Sonic’s business model different is that it is built around a large, decentralized network of local laboratories rather than one single product. Demand is tied to everyday medical care, so the business depends less on a one-time sale and more on repeat testing from patients and physicians over time.
Revenue Growth: Sonic Healthcare reported first-half FY26 revenue of $5.445 billion, with organic growth of 5% and strong top-line momentum across key markets.
Profitability: Net profit was $262 million and earnings per share reached AUD 0.531. EBITDA was $907 million, with margins up 30 basis points versus the prior year.
Guidance Reaffirmed: Full-year EBITDA guidance of $1.87–$1.95 billion (constant currency) was reaffirmed, and depreciation guidance was lowered.
Dividend Increase: Progressive interim dividend of AUD 0.45, up 2.3% on the prior year, with a 60% franking level.
Cost Control & Leverage: Management emphasized ongoing cost control, especially labor, operating leverage, and synergy realization as drivers of margin improvement.
US Operations: Operating review and restructuring is underway in the US, aiming to rationalize anatomical pathology and improve profitability; margin impact expected to lessen in H2.
Capital Management: Several property sale and leaseback initiatives are in progress, with potential proceeds earmarked for share buybacks.
FX Impact: Currency tailwind in H1 will be lower for the full year; H2 faces a currency headwind based on current rates.